“Functional and Anatomical Outcomes Following Intravitreal Bevacizumab in Treatment-Naïve Centre-Involving Diabetic Macular Edema: A 3-Month Prospective Evaluation” (2025) Journal of Health and Rehabilitation Sciences, 4(2), pp. 1–10. doi:10.33700/jhrs.4.2.172.